Back to CITADEL ADVISORS LLC CITADEL ADVISORS LLC

PASGPASG
Showing 7 of 25 quarters

Position history for CITADEL ADVISORS LLCCITADEL ADVISORS LLC's holdings in Passage Bio, Inc.

CITADEL ADVISORS LLC holds 2.9M shares of PASG (Passage Bio, Inc.), worth $4.3M as of 2026-Q2. This is a new position. PASG represents 0.0% of CITADEL ADVISORS LLC's portfolio.

Current Value

$4.3M

Current Shares

2.9M

Total Value Change

+$4M

Total Shares Change

+2.5M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
New
2.9M
-
$4.3M0.0%$4.88
37
2026-Q1
Exited
0
-100.0%
$00.0%$8.00
0
2025-Q4
Decreased
17,660
-7.5%
$208,3880.0%$10.70
0
2025-Q3
Decreased
19,091
-92.3%
$152,9190.0%$8.14
0
2025-Q2
New
247,682
-
$99,1470.0%$6.62
33
2024-Q4
Exited
0
-100.0%
$00.0%$13.30
0
2024-Q3
Increased
402,525
+154.3%
$281,7680.0%$13.68
38

Other major holders of PASG: ALKEON CAPITAL MANAGEMENT LLC, Woodline Partners LP, RA CAPITAL MANAGEMENT, L.P., GEODE CAPITAL MANAGEMENT, LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used